• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

INOCA：非阻塞性冠状动脉缺血。

INOCA: Ischemia in non-obstructive coronary arteries.

作者信息

AlShaikh Shereen, Rohm Charlene L, Sutton Nadia R, Burgess Sonya N, Alasnag Mirvat

机构信息

Adult Cardiology Department, Mohammed bin Khalifa Cardiac Centre, Riffa, Bahrain.

Department of Internal Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.

出版信息

Am Heart J Plus. 2024 Apr 16;42:100391. doi: 10.1016/j.ahjo.2024.100391. eCollection 2024 Jun.

DOI:10.1016/j.ahjo.2024.100391
PMID:38680648
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11043816/
Abstract

This article provides a summary of the clinical spectrum of no obstructive coronary arteries. We describe the pathologies, invasive and noninvasive assessment, and management strategies.

摘要

本文提供了无阻塞性冠状动脉临床谱的概述。我们描述了其病理情况、有创和无创评估以及管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7c/11043816/e5d2bbfd900e/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7c/11043816/ec18429482be/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7c/11043816/0c2350af3f36/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7c/11043816/8c51592c0a94/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7c/11043816/ed8c117b8679/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7c/11043816/e5d2bbfd900e/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7c/11043816/ec18429482be/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7c/11043816/0c2350af3f36/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7c/11043816/8c51592c0a94/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7c/11043816/ed8c117b8679/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7c/11043816/e5d2bbfd900e/fx2.jpg

相似文献

1
INOCA: Ischemia in non-obstructive coronary arteries.INOCA：非阻塞性冠状动脉缺血。
Am Heart J Plus. 2024 Apr 16;42:100391. doi: 10.1016/j.ahjo.2024.100391. eCollection 2024 Jun.
2
Evaluation of Ischemia with No Obstructive Coronary Arteries (INOCA) and Contemporary Applications of Cardiac Magnetic Resonance (CMR).无阻塞性冠状动脉疾病（INOCA）的评估和心脏磁共振（CMR）的当代应用。
Medicina (Kaunas). 2023 Aug 29;59(9):1570. doi: 10.3390/medicina59091570.
3
Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction.根据冠状动脉微血管功能障碍，非阻塞性冠状动脉疾病中的缺血的临床相关性。
J Am Heart Assoc. 2022 May 3;11(9):e025171. doi: 10.1161/JAHA.121.025171. Epub 2022 Apr 27.
4
Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease.稳定型缺血性心脏病患者的缺血但非阻塞性冠状动脉疾病。
Int J Cardiol. 2022 Feb 1;348:1-8. doi: 10.1016/j.ijcard.2021.12.013. Epub 2021 Dec 11.
5
Prevalence and disease features of myocardial ischemia with non-obstructive coronary arteries: Insights from a dynamic CT myocardial perfusion imaging study.静息 CT 心肌灌注成像研究：非阻塞性冠状动脉心肌缺血的患病率和疾病特征。
Int J Cardiol. 2021 Jul 1;334:142-147. doi: 10.1016/j.ijcard.2021.04.055. Epub 2021 Apr 28.
6
Ischemia With Nonobstructive Coronary Arteries: Insights From the ISCHEMIA Trial.无阻塞性冠状动脉疾病的缺血：来自 ISCHEMIA 试验的见解。
JACC Cardiovasc Imaging. 2023 Jan;16(1):63-74. doi: 10.1016/j.jcmg.2022.06.015. Epub 2022 Sep 14.
7
Invasive Coronary Assessment in Myocardial Ischemia with No Obstructive Coronary Arteries.无阻塞性冠状动脉的心肌缺血患者的有创冠状动脉评估
Curr Atheroscler Rep. 2023 Oct;25(10):729-740. doi: 10.1007/s11883-023-01144-9. Epub 2023 Sep 8.
8
Pathophysiologic Basis and Diagnostic Approaches for Ischemia With Non-obstructive Coronary Arteries: A Literature Review.非阻塞性冠状动脉缺血的病理生理基础及诊断方法：文献综述
Front Cardiovasc Med. 2022 Mar 17;9:731059. doi: 10.3389/fcvm.2022.731059. eCollection 2022.
9
Ischemia with No Obstructive Arteries (INOCA): A Review of the Prevalence, Diagnosis and Management.无阻塞性动脉粥样硬化性缺血（INOCA）：患病率、诊断和治疗的综述。
Curr Probl Cardiol. 2023 Jan;48(1):101420. doi: 10.1016/j.cpcardiol.2022.101420. Epub 2022 Sep 30.
10
Molecular Hallmarks of Ischemia with Non-Obstructive Coronary Arteries: The "INOCA versus Obstructive CCS" Challenge.非阻塞性冠状动脉缺血的分子特征：“INOCA 与阻塞性冠状动脉疾病（CCS）”的挑战
J Clin Med. 2022 Mar 19;11(6):1711. doi: 10.3390/jcm11061711.

引用本文的文献

1
Follow-up of patients with myocardial ischemia without obstructive coronary lesions.无阻塞性冠状动脉病变的心肌缺血患者的随访
Arch Peru Cardiol Cir Cardiovasc. 2025 Jun 27;6(2):69-74. doi: 10.47487/apcyccv.v6i2.472. eCollection 2025 Apr-May.
2
Coronary Artery Spasm: From Physiopathology to Diagnosis.冠状动脉痉挛：从病理生理学到诊断
Life (Basel). 2025 Apr 3;15(4):597. doi: 10.3390/life15040597.
3
Endothelial microRNAs in INOCA patients with diabetes mellitus.糖尿病合并无症状性心肌缺血患者的内皮 microRNAs。

本文引用的文献

1
Comprehensive Management of ANOCA, Part 2-Program Development, Treatment, and Research Initiatives: JACC State-of-the-Art Review.ANOCA 的综合管理，第 2 部分-项目开发、治疗和研究计划：JACC 最新技术评论。
J Am Coll Cardiol. 2023 Sep 19;82(12):1264-1279. doi: 10.1016/j.jacc.2023.06.044.
2
Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review.心源性卒中的综合管理，第 1 部分-定义、患者人群和诊断：JACC 最新观点述评。
J Am Coll Cardiol. 2023 Sep 19;82(12):1245-1263. doi: 10.1016/j.jacc.2023.06.043.
3
INOCA/ANOCA: Mechanisms and novel treatments.
Cardiovasc Diabetol. 2024 Jul 22;23(1):268. doi: 10.1186/s12933-024-02331-x.
隐匿性冠心病/急性非阻塞性冠状动脉综合征：发病机制与新型治疗方法
Am Heart J Plus. 2023 Jun;30. doi: 10.1016/j.ahjo.2023.100302. Epub 2023 May 12.
4
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology.经皮冠状动脉介入治疗的应用冠状动脉生理学：欧洲心脏病学会欧洲经皮心血管介入协会（EAPCI）的临床共识声明。
EuroIntervention. 2023 Aug 21;19(6):464-481. doi: 10.4244/EIJ-D-23-00194.
5
Myocardial Perfusion PET for the Detection and Reporting of Coronary Microvascular Dysfunction: A JACC: Cardiovascular Imaging Expert Panel Statement.用于检测和报告冠状动脉微血管功能障碍的心肌灌注正电子发射断层显像：美国心脏病学会杂志：心血管影像专家小组声明
JACC Cardiovasc Imaging. 2023 Apr;16(4):536-548. doi: 10.1016/j.jcmg.2022.12.015. Epub 2023 Feb 8.
6
Updates on Pharmacologic Management of Microvascular Angina.微血管性心绞痛的药物治疗进展。
Cardiovasc Ther. 2022 Oct 25;2022:6080258. doi: 10.1155/2022/6080258. eCollection 2022.
7
Beyond Coronary Artery Disease: Assessing the Microcirculation.超越冠状动脉疾病：评估微循环。
Interv Cardiol Clin. 2023 Jan;12(1):119-129. doi: 10.1016/j.iccl.2022.09.010.
8
Ischemia With Nonobstructive Coronary Arteries: Insights From the ISCHEMIA Trial.无阻塞性冠状动脉疾病的缺血：来自 ISCHEMIA 试验的见解。
JACC Cardiovasc Imaging. 2023 Jan;16(1):63-74. doi: 10.1016/j.jcmg.2022.06.015. Epub 2022 Sep 14.
9
Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols.乙酰胆碱冠状动脉内激发试验的安全性及其对标准方案的影响。
J Am Coll Cardiol. 2022 Jun 21;79(24):2367-2378. doi: 10.1016/j.jacc.2022.03.385.
10
Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries.稳定型心肌缺血或心肌梗死伴非阻塞性冠状动脉患者乙酰胆碱试验的安全性和预后相关性。
EuroIntervention. 2022 Oct 7;18(8):e666-e676. doi: 10.4244/EIJ-D-21-00971.